Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 25,539 | 0 | 0 | 0 | 8,255 |
| Gross Profit | 25,539 | N/A | N/A | N/A | 8,255 |
| Operating Expenses | 28,121 | 11,112 | 7,675 | 11,302 | 30,064 |
| Operating Income | -2,582 | -11,112 | -7,675 | -11,302 | -21,809 |
| Interest Expense | -47 | 0 | 0 | 0 | 7 |
| Other Income | 70 | 421 | -148 | 383 | 719 |
| Pre-tax Income | -2,465 | -10,691 | -7,823 | -10,919 | -21,097 |
| Income Tax | 3,011 | -2,059 | 713 | 675 | N/A |
| Net Income Continuous | -5,476 | -8,632 | -8,536 | -11,594 | -21,097 |
| Net Income Extraordinary | N/A | 4,428 | N/A | N/A | N/A |
| Net Income | $-5,476 | $-4,204 | $-8,536 | $-11,594 | $-21,097 |
| EPS Basic Total Ops | -2,090.21 | -7,436.74 | -212,607.30 | -262,948.30 | -34,823.63 |
| EPS Basic Continuous Ops | -2,089.25 | -10,382.41 | -158,088.50 | -214,723.40 | -34,746.46 |
| EPS Diluted Total Ops | -2,090.21 | -7,436.74 | -212,607.30 | -262,948.30 | -34,823.63 |
| EPS Diluted Continuous Ops | -2,089.25 | -10,382.41 | -158,088.50 | -214,723.40 | -34,746.46 |
| EBITDA(a) | $-2,532 | $-11,023 | $-7,592 | $-11,208 | $-21,223 |